Your request to link to rcsb for BDBM50076390

• 6BJR: crystal structure of prothrombin mutant s101c/a470c (10.1038/S41598-018-21304-1 )
• 1CFI: nmr structure of calcium ion-bound gamma-carboxy-glutamic acid-rich domain of factor ix (10.1021/BI00038A005 )
• 2AEI: crystal structure of a ternary complex of factor viia/tissue factor and 2-[[6-[3-(aminoiminomethyl)phenoxy]-3,5-difluro-4-[(1-methyl-3- phenylpropyl)amino]-2-pyridinyl]oxy]-benzoic acid (10.1016/J.BMCL.2005.07.059 )
• 2AER: crystal structure of benzamidine-factor viia/soluble tissue factor complex. (10.1074/JBC.M509971200 )
• 1W0Y: tf7a_3771 complex (10.1016/J.BMCL.2004.10.092 )
• 2PF2: the ca+2 ion and membrane binding structure of the gla domain of ca- prothrombin fragment 1 (10.1021/BI00124A016 )
• 4O03: crystal structure of ca2+ bound prothrombin deletion mutant residues 146-167 (10.1073/PNAS.1403779111 )
• 1TGG: rh3 designed right-handed coiled coil trimer (10.1016/J.JMB.2004.06.051 )
• 1LQV: crystal structure of the endothelial protein c receptor with phospholipid in the groove in complex with gla domain of protein c. (10.1074/JBC.C200163200 )
• 1Z6J: crystal structure of a ternary complex of factor viia/tissue factor/pyrazinone inhibitor (10.1016/J.BMCL.2005.04.037 )
• 3JTC: importance of mg2+ in the ca2+-dependent folding of the gamma- carboxyglutamic acid domains of vitamin k-dependent clotting and anticlotting proteins (10.1016/J.JMB.2013.02.017 )
• 1Q8H: crystal structure of porcine osteocalcin (10.1038/NATURE02079 )
• 1WQV: human factor viia-tissue factor complexed with propylsulfonamide-d- thr-met-p-aminobenzamidine (10.1016/J.BBRC.2004.09.182 )
• 2ZP0: human factor viia-tissue factor complexed with benzylsulfonamide-d- ile-gln-p-aminobenzamidine
• 1WHE: coagulation factor, nmr, 20 structures (10.1021/BI960633J )
• 1WHF: coagulation factor, nmr, 15 structures (10.1021/BI960633J )
• 1AG7: conotoxin gs, nmr, 20 structures (10.1016/S0969-2126(97)00212-8 )
• 5TBG: the solution structure of the magnesium-bound conantokin-r1b mutant (10.1021/ACS.BIOCHEM.6B00962 )
• 5TBQ: the solution structure of the magnesium-bound conantokin-r1b mutant (10.1021/ACS.BIOCHEM.6B00962 )
• 5TBR: the solution structure of the magnesium-bound conantokin-r1b mutant (10.1021/ACS.BIOCHEM.6B00962 )
• 2EC9: crystal structure analysis of human factor viia , souluble tissue factor complexed with bcx-3607 (10.1107/S0907444907014187 )
• 2ZZU: human factor viia-tissue factor complexed with ethylsulfonamide-d-5- (3-carboxybenzyloxy)-trp-gln-p-aminobenzamidine (10.1248/CPB.58.38 )
• 1WUN: human factor viia-tissue factor complexed with ethylsulfonamide-d-trp- gln-p-aminobenzamidine (10.1016/J.BBRC.2004.12.042 )
• 7SMU: crystal structure of consomatin-ro1 10.1126/SCIADV.ABK1410 )
• 2ZWL: human factor viia-tissue factor complexed with highly selective peptide inhibitor
• 2C4F: crystal structure of factor vii.stf complexed with pd0297121 (10.1016/J.BMCL.2005.10.076 )
• 1MGX: coagulation factor, mg(ii), nmr, 7 structures (backbone atoms only) (10.1074/JBC.271.27.16227 )
• 5EDK: crystal structure of prothrombin deletion mutant residues 146-167 ( form ii ). (10.1074/JBC.M115.700401 )
• 5EDM: crystal structure of prothrombin deletion mutant residues 154-167 ( form i ) (10.1074/JBC.M115.700401 )
• 2FIR: crystal structure of dfpr-viia/stf (10.1074/JBC.M509971200 )
• 1WTG: human factor viia-tissue factor complexed with ethylsulfonamide-d- biphenylalanine-gln-p-aminobenzamidine (10.1016/J.BBRC.2004.11.108 )
• 4ZMA: crystal structure of a fviia-trypsin chimera (st) in complex with soluble tissue factor (10.1074/JBC.M115.698613 )
• 2MZM: the solution structure of the magnesium-bound conantokin-g (10.1074/JBC.M115.650341 )
• 2MZL: the solution structure of the magnesium-bound conantokin-g mutant (10.1074/JBC.M115.650341 )
• 6R2W: crystal structure of the super-active fviia variant vyt in complex with tissue factor (10.1074/JBC.RA119.009183 )
• 1IOD: crystal structure of the complex between the coagulation factor x binding protein from snake venom and the gla domain of factor x (10.1073/PNAS.131179698 )
• 1ONU: nmda receptor antagonist, conantokin-g, nmr, 17 structures (10.1074/JBC.272.4.2291 )
• 4YLQ: crystal structure of a fviia-trypsin chimera (ft) in complex with soluble tissue factor (10.1074/JBC.M115.698613 )
• 1AD7: nmr structure of metal-free conantokin g, 1 structure (10.1021/BI970321W )
• 2SPT: differences in the metal ion structure between sr-and ca-prothrombin fragment 1 (10.1021/BI00171A006 )
• 2B8O: crystal structure of glu-gly-arg-chloromethyl ketone-factor viia/soluble tissue factor complex
• 1VZM: osteocalcin from fish argyrosomus regius (10.1021/BI048336Z )
• 2DPQ: the crystal structures of the calcium-bound con-g and con-t(k7gamma) dimeric peptides demonstrate a novel metal-dependent helix-forming motif (10.1021/JA065722Q )
• 2MZK: the solution structure of the magnesium-bound conantokin rlb (10.1074/JBC.M115.650341 )
• 1P0S: crystal structure of blood coagulation factor xa in complex with ecotin m84r (10.1021/BI027320A )
• 1AWY: nmr structure of calcium bound conformer of conantokin g, minimized average structure (10.1021/BI9718550 )
• 1WSS: human factor viia-tissue factor in complex with peptide-mimetic inhibitor that has two charged groups in p2 and p4 (10.1107/S1744309105000047 )
• 6VEQ: con-ins g1 in complex with the human insulin microreceptor in turn in complex with fv 83-7 (10.1038/S41594-020-0430-8 )
• 1MTQ: three-dimensional solution structure of alpha-conotoxin gid by nmr spectroscopy (10.1074/JBC.M210280200 )
• 2MYZ: the solution structure of the magnesium-bound conantokin-r1b mutant (10.1074/JBC.M115.650341 )
• 1Q3M: 1h nmr structure bundle of bovine ca2+-osteocalcin (10.1021/BI034470S )
• 6C2W: crystal structure of human prothrombin mutant s101c/a470c (10.1038/S41598-018-21304-1 )
• 3TH2: mg2+ is required for optimal folding of the gamma-carboxyglutamic acid (gla) domains of vitamin k-dependent clotting factors at physiological ca2+
• 3TH4: mg2+ is required for optimal folding of the gamma-carboxyglutamic acid (gla) domains of vitamin k-dependent clotting factors at physiological ca2+
• 1WV7: human factor viia-tissue factor complexed with ethylsulfonamide-d-5- propoxy-trp-gln-p-aminobenzamidine (10.1016/J.BBRC.2004.12.042 )
• 2M7R: nmda receptor antagonist, conantokin bk-b, nmr, 20 structure (10.1016/J.TOXICON.2014.01.016 )
• 5JYQ: structure of conus geographus insulin g1 (10.1038/NSMB.3292 )
• 2A2Q: complex of active-site inhibited human coagulation factor viia with human soluble tissue factor in the presence of ca2+, mg2+, na+, and zn2+ (10.1074/JBC.M509971200 )
• 1W2K: tf7a_4380 complex (10.1016/J.BMCL.2004.10.092 )
• 1ONT: nmda receptor antagonist, conantokin-t, nmr, 17 structures (10.1074/JBC.272.4.2291 )
• 1DAN: complex of active site inhibited human blood coagulation factor viia with human recombinant soluble tissue factor (10.1038/380041A0 )
• 1J34: crystal structure of mg(ii)-and ca(ii)-bound gla domain of factor ix complexed with binding protein (10.1074/JBC.M300650200 )
• 1WCT: a novel conotoxin from conus textile with unusual post-translational modifications reduces presynaptic calcium influx, nmr, 1 structure, glycosylated protein (10.1073/PNAS.96.10.5758 )
• 2DPR: the crystal structures of the calcium-bound con-g and con-t(k7glu) dimeric peptides demonstrate a novel metal-dependent helix-forming motif (10.1021/JA065722Q )
• 1PFX: porcine factor ixa (10.1073/PNAS.92.21.9796 )
• 2O6N: rh4b: designed right-handed coiled coil tetramer with all biological amino acids (10.1110/PS.062702907 )
• 1J35: crystal structure of ca(ii)-bound gla domain of factor ix complexed with binding protein (10.1074/JBC.M300650200 )
• 1NL1: bovine prothrombin fragment 1 in complex with calcium ion (10.1038/NSB971 )
• 1NL0: crystal structure of human factor ix gla domain in complex of an inhibitory antibody, 10c12 (10.1074/JBC.M314011200 )
• 1NL2: bovine prothrombin fragment 1 in complex with calcium and lysophosphotidylserine (10.1038/NSB971 )
• 4IBL: rubidium sites in blood coagulation factor viia